World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
124
Citations
66173
World Ranking
3191
National Ranking
1764

Research.com Recognitions

  • Member of the Association of American Physicians
  • Member of the Association of American Physicians

Overview

Richard E. Chaisson is affiliated with Johns Hopkins University in the United States. Their research primarily focuses on Medicine, with a particular emphasis on Infectious Diseases, Epidemiology, Surgery, Pediatrics, Perinatology and Child Health, and Public Health, Environmental and Occupational Health.

Their work covers several key topics, including:

  • Tuberculosis Research and Epidemiology
  • Pneumocystis jirovecii pneumonia detection and treatment
  • HIV/AIDS drug development and treatment
  • Infectious Diseases and Tuberculosis
  • Pneumonia and Respiratory Infections
  • Mycobacterium research and diagnosis
  • HIV/AIDS Research and Interventions

The scientist has published extensively in multiple venues. Frequent publication venues include:

  • The International Journal of Tuberculosis and Lung Disease
  • Clinical Infectious Diseases
  • IJTLD OPEN
  • The Lancet HIV
  • American Journal of Respiratory and Critical Care Medicine

Richard E. Chaisson's recent papers highlight ongoing research interests and contributions to the field. Notable publications include:

  • "Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis," 2021, New England Journal of Medicine
  • "Scientific advances and the end of tuberculosis: a report from the Lancet Commission on Tuberculosis," 2023, The Lancet
  • "Clinical standards for the diagnosis, treatment and prevention of TB infection," 2022, The International Journal of Tuberculosis and Lung Disease
  • "Once-weekly rifapentine and isoniazid for tuberculosis prevention in patients with HIV taking dolutegravir-based antiretroviral therapy: a phase 1/2 trial," 2020, The Lancet HIV
  • "A partially randomised trial of pretomanid, moxifloxacin and pyrazinamide for pulmonary TB," 2021, The International Journal of Tuberculosis and Lung Disease

Frequent co-authors collaborating with Richard E. Chaisson include:

  • Susan Swindells
  • Gavin Churchyard
  • Kelly E. Dooley
  • Neil Martinson
  • Payam Nahid

Richard E. Chaisson has been recognized as a Member of the Association of American Physicians.

Best Publications

  • Circulating microRNAs in sera correlate with soluble biomarkers of immune activation but do not predict mortality in ART treated individuals with HIV-1 infection : a case control study

    Daniel D. Murray;Kazuo Suzuki;Matthew Law;Jonel Trebicka

  • Identification of a Reservoir for HIV-1 in Patients on Highly Active Antiretroviral Therapy

    Diana Finzi;Monika Hermankova;Theodore Pierson;Lucy M. Carruth

  • Latent infection of CD4 + T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy

    Diana Finzi;Joel N Blankson;Janet M Siliciano;Joseph Bernard Margolick

  • American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: treatment of tuberculosis.

    Henry M Blumberg;William J Burman;Richard E Chaisson;Charles L Daley

  • Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis.

    Payam Nahid;Susan E. Dorman;Narges Alipanah;Pennan M. Barry

  • Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection.

    Mark S. Sulkowski;David L. Thomas;Richard E. Chaisson;Richard D. Moore

  • Three Months of Rifapentine and Isoniazid for Latent Tuberculosis Infection

    Timothy R. Sterling;M. Elsa Villarino;Andrey S. Borisov;Nong Shang

  • Highly active antiretroviral therapy in a large urban clinic: risk factors for virologic failure and adverse drug reactions.

    Gregory M. Lucas;Richard E. Chaisson;Richard D. Moore

  • Latent Mycobacterium tuberculosis Infection

    Haileyesus Getahun;Alberto Matteelli;Richard E. Chaisson;Mario Raviglione

  • Cocaine use and HIV infection in intravenous drug users in San Francisco.

    Richard E. Chaisson;Peter Bacchetti;Dennis Osmond;Barbara Brodie

  • Seropositivity for HIV and the development of AIDS or AIDS related condition: three year follow up of the San Francisco General Hospital cohort.

    Andrew R. Moss;Peter Bacchetti;Dennis Osmond;Walter Krampf

  • Incidence and Natural History of Cytomegalovirus Disease in Patients with Advanced Human Immunodeficiency Virus Disease Treated with Zidovudine

    Joel E. Gallant;Richard D. Moore;Richard D. Moore;Douglas D. Richman;Douglas D. Richman;Jeanne Keruly;Jeanne Keruly

  • Hepatotoxicity associated with nevirapine or efavirenz-containing antiretroviral therapy: role of hepatitis C and B infections.

    Mark S. Sulkowski;David L. Thomas;David L. Thomas;Shruti H. Mehta;Richard E. Chaisson

  • Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries.

    Haileyesus Getahun;Alberto Matteelli;Ibrahim Abubakar;Mohamed Abdel Aziz

  • Treatment of tuberculosis in patients with advanced human immunodeficiency virus infection.

    Peter M. Small;Gisela F. Schecter;Philip C. Goodman;Merle A. Sande

  • Natural history of HIV infection in the era of combination antiretroviral therapy.

    Richard D. Moore;Richard E. Chaisson

  • Hepatitis C and progression of HIV disease.

    Mark S. Sulkowski;Richard D. Moore;Shruti H. Mehta;Richard E. Chaisson

  • USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus

    David Lanier;Neil Schram;Ellen Cooper;Kenneth A. Freedberg

  • Tuberculosis in patients with the acquired immunodeficiency syndrome. Clinical features, response to therapy, and survival.

    Richard E. Chaisson;Gisela F. Schecter;Charles P. Theuer;George W. Rutherford

  • Rifapentine and isoniazid once a week versus rifampicin and isoniazid twice a week for treatment of drug-susceptible pulmonary tuberculosis in HIV-negative patients: A randomised clinical trial

    Debra Benator;Mondira Bhattacharya;Lorna Bozeman;William Burman

Frequent Co-Authors

Richard D. Moore
Richard D. Moore Johns Hopkins University
Gavin J. Churchyard
Gavin J. Churchyard Aurum Institute
William R. Bishai
William R. Bishai Johns Hopkins University
Katherine Fielding
Katherine Fielding University of London
Lawrence H. Moulton
Lawrence H. Moulton Johns Hopkins University
Jean B. Nachega
Jean B. Nachega University of Pittsburgh
Elizabeth L. Corbett
Elizabeth L. Corbett London School of Hygiene & Tropical Medicine
Gary Maartens
Gary Maartens University of Cape Town
Timothy R. Sterling
Timothy R. Sterling Vanderbilt University Medical Center
Eric L. Nuermberger
Eric L. Nuermberger Johns Hopkins University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Considering a career in medicine opens many doors beyond a traditional MD degree. There are several flexible online degree options that can help you launch or advance your career in healthcare. For those interested in clinical care, some students are drawn to nursing. In fact, there are nursing school without teas test requirements, allowing prospective nurses to enroll without standardized entry exams, which can streamline the application process.

If you are interested in leadership, business, or hospital management, you might explore healthcare administration degrees. These programs, often available in accelerated formats, prepare graduates for management roles in a rapidly growing industry.

Registered nurses seeking further specialization can pursue rn to fnp bridge programs, which allow RNs to earn their MSN and become Family Nurse Practitioners through efficient bridge curricula.

For those interested in preventive health or dietetics, an online nutrition degree can provide the foundation for work in wellness, sports nutrition, or public health.

Each of these online health programs offers unique pathways tailored to different interests and career goals, making healthcare education more accessible than ever.

Best Scientists Citing Richard E. Chaisson

Trending Scientists

Recently Published Articles